comparemela.com
Home
Live Updates
Microsoft Build Day 1: Analysts Applaud AI-Infusion, GenAI Adoption - Microsoft (NASDAQ:MSFT) : comparemela.com
Microsoft Build Day 1: Analysts Applaud AI-Infusion, GenAI Adoption - Microsoft (NASDAQ:MSFT)
Microsoft has a Buy rating with a 12-month price target of $515 from Goldman Sachs, and $450 from Mizuho Securities.
Related Keywords
Washington ,
United States ,
Gregg Moskowitz ,
Kash Rangan ,
Microsoft Corp ,
Team Copilot ,
Foundation Model Evolution ,
Microsoft ,
Goldman Sachs ,
Emphasizing Microsoft ,
Leading Role ,
Model Evolution ,
Hardware Innovations ,
Nadella Says Stop Treating ,
Windows Copilot Runtime ,
Large Language Models ,
Small Language Models ,
Time Intelligence ,
Microsoft Build ,
Mizuho Securities ,
Microsoft Unveils ,
comparemela.com © 2020. All Rights Reserved.